HSS Receives Generous Gift to Establish Endowment to Advance Orthopedic Translational Research
Hospital for Special Surgery (HSS) is pleased to announce that it has received a generous contribution from Steven P. and Brenda E. Arnoczky to establish the Steven P. and Brenda E. Arnoczky Endowment for Translational Orthopedic Research. This commitment is intended to provide support to talented investigators at HSS leading innovative studies to enhance care of orthopedic patients.
Steven Arnoczky, DVM, a veterinary surgeon and renowned scientist started his illustrious career in orthopaedic translational research at HSS over 45 years ago and was the founding Director of the Laboratory for Comparative Orthopaedic Research. Mentored by pioneers in orthopedic research at HSS, John L. Marshall, DVM, MD, Philip D. Wilson, Jr, MD, Russell F. Warren, MD, and Peter A. Torzilli, PhD. Dr. Arnoczky established one of the very first research programs in the U.S. focusing on soft tissues, and he was an early innovator in establishing collaborations between scientists and clinicians. His approach laid the foundation for his transformative research on preserving knee and shoulder joints after injury. Dr. Arnoczky brought the unique combined perspectives of a clinician-scientist, an individual who had a deep understanding of the clinical problems physicians face, and the scientific expertise to design novel laboratory studies to answer these questions. His approach led to many seminal discoveries that have advanced patient care. His research has been recognized by over 30 national and international awards, culminating in his election to the American Orthopaedic Society for Sports Medicine Hall of Fame, the highest honor in sports medicine research. Embodying the HSS philosophy of supporting the next generation of surgeons and scientists, Dr. Arnoczky supported numerous trainees, including HSS faculty, Scott A. Rodeo, MD, sports medicine surgeon and vice chair of Orthopedic Research and co-director of the Orthopedic Soft Tissue Research Program at HSS, and Jo A. Hannafin, MD ,PhD, through mentorship and collaboration as they developed federally funded research programs.
During his tenure at HSS, Dr. Arnoczky met his wife, Brenda, who was head nurse on the neurology/neurosurgery floor at New York Hospital (now New York-Presbyterian Hospital). This gift memorializes the role that HSS played in their lives. “HSS started me on an orthopaedic research career that would change my life. Like so many others whose lives have been enhanced by their time at HSS, Brenda and I are so very grateful for what HSS has meant to us. We are happy to be able to pay it forward with this enduring support,” said Dr. Arnoczky.
As the No. 1 hospital in orthopedics for 13 straight years by U.S. News & World Report (2022-2023), HSS is a leader in research aimed at improving the lives of patients suffering from debilitating orthopedic and rheumatic conditions such as arthritis, bone and soft tissue injuries, autoimmune diseases, and musculoskeletal pain and deformities.
“This exceptional gift will help to ensure that there is sustained funding for leading-edge investigations taking place at HSS. We are pleased that Steven is building upon his past contributions to HSS as a scientist and mentor to many trainees with this gift, made with his wife, Brenda, to make a lasting difference for HSS and the field of orthopedics,” said Louis A. Shapiro, CEO at HSS.
“HSS is committed to delivering unsurpassed care and improving the field. The Arnoczkys’ gift will help us to continue developing treatments and explore emerging research topics to best improve clinical outcomes as grants will be awarded annually to projects and initiatives aimed at having a clear and measurable impact on patients,” said Dr. Rodeo.
Through a competitive process, medical students, residents, and fellows collaborating with physicians and scientists on pilot translational orthopedic research projects will be invited to apply for a grant. A selection committee comprising of leading HSS physicians and scientists will evaluate applications. Grants will cover the cost of personnel, equipment, supplies, and other key research resources specific to investigators and their projects.
“We are deeply grateful for Steven and Brenda’s generosity which will enable talented medical students, residents, and fellows to accelerate breakthroughs that change people’s lives,” said Bryan T. Kelly, MD, MBA, president, surgeon-in-chief and medical director at HSS.
The Arnoczky Endowment for Translational Orthopedic Research will build on HSS’s leadership position as the largest musculoskeletal research facility in the world.
“To see Steven give back to HSS in this way is deeply meaningful to those of us who worked with him early in his career. We join the entire HSS community in thanking the Arnoczkys and celebrating this visionary gift,” said Drs. Warren, Torzilli, and Hannafin, co-founders of the HSS Soft Tissue Research Laboratory.
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 14th consecutive year), No. 2 in rheumatology by U.S. News & World Report (2023-2024), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report “Best Children’s Hospitals” list (2023-2024). In a survey of medical professionals in more than 20 countries by Newsweek, HSS is ranked world #1 in orthopedics for a third consecutive year (2023). Founded in 1863, the Hospital has the lowest readmission rates in the nation for orthopedics, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center five consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnosis, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Innovation Institute works to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu.